ArticleThe Journal of clinical investigation2016

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Trevelyan R Menheniott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.